Rather than being in competition with one another, Cuba’s biotechnology and medical research facilities work in collaboration to find solutions to Cuba’s health problems, including lung cancer. Their collaborative and self-sustaining medical infrastructure allows them the creativity to develop and test drugs like CIMAvax-EGF, a lung cancer vaccine.
In collaboration with Roswell Park Comprehensive Cancer Center in New York, Cuba’s Centro de Inmunolgía Molecular (CIM), developed a 2023 study on the preventative effects of CIMAvax-EGF. According to Mary Reid, BSN, MSPH, PhD, Chief of Cancer Screening, Survivorship and Mentorship at Roswell Park, “We have strong preliminary evidence that this stalls the growth of lung tumors.” Their next step, then, is to study whether the vaccine can decrease the risk of developing lung cancer.
Read more: https://www.roswellpark.org/cancertalk/202302/vaccine-prevent-lung-cancer
Cuba SÍ Colorado 